IMAGES IN GASTROENTEROLOGY AND HEPATOLOGY

 

Yttrium-90-Induced Gastropathy: A Potential Equivocal Finding

Gastropatia induzida por yttrium-90: um potencial confundidor

 

Rui Castro^a, Diogo Libânio^a, Pedro Heitor^b, Manuel Jácome^b, Rui Silva^a

^aDepartment of Gastroenterology, Portuguese Oncology Institute of Porto, Porto, Portugal; ^bDepartment of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal

^* Corresponding author.

 

Keywords: Colorectal cancer, Gastropathy, Selective internal radiation therapy, Yttrium-90

Palavras-Chave: Cancro colo-retal, Gastropatia, Radioterapia seletiva interna, Yttrium-90

 

Introduction

Selective internal radiation therapy with yttrium-90 (Y-90) spheres is used in the treatment of unresectable hepatic malignancies. With the increasing use of selective internal radiation therapy, there has been some reports of secondary associated gastric lesion such as ischemic ulceration.

Case Report

We report the case of a 44-year-old female admitted to our institute in January 2016 with the diagnosis of sigmoid colon adenocarcinoma. At the time of the diagnosis, the patient presented multiple liver metastases with dimensions between 1 and 4 cm. Despite this fact, the patient was submitted to a left colectomy in April 2016, with a chirurgical staging of pT4bN0M1. In this context, she initiated palliative chemotherapy with stabilization of liver metastatic disease. At this point, the patient was presented in a multidisciplinary group consultation and it was decided to perform selective internal radiation therapy with Y-90 spheres. The patient was submitted to two sessions of radioembolization, one in January 2018 and the other in February 2018. After the second session, the patient developed sudden onset of epigastric pain. Based on these symptoms, she performed a gastroscopy in March 2018 that revealed a pyloric circumferential ulcer with some ischemic features (Fig. 1), and biopsy samples were collected from this lesion. Histopathologic examination revealed ischemic and regenerative changes, significant inflammatory infiltrate and some vessels occluded with Y-90 microspheres (Fig. 2). After the diagnosis, the patient started therapy with proton pump inhibitors with only mild symptoms of regression. Fortunately, the pyloric ulceration did not evolve to a stricture, and the patient never experienced gastric outlet obstruction symptoms.

 

 

 

 

Discussion

Selective internal radiation therapy with Y-90 spheres is generally well tolerated, but up to 27% of the patients may experience gastrointestinal adverse events resulting from migration or misallocation of Y-90 spheres. These adverse events may include abdominal pain, nausea, vomiting, ulceration, cholecystitis, pancreatitis, and liver damage. In this study, we present a case of gastric ulceration. This type of lesions can persist for several months after initial therapy as a result of ischemia, and its management can be challenging due to the limited role of acid-suppressing medications. Gastrectomy could be considered for refractory cases. [1–3]. Due to its potential puzzling effect regarding clinical and endoscopic features, it is important for endoscopists to always consider this differential diagnosis in patients presenting with abdominal pain and previous history of radioembolization therapy. With this case, we provide a striking and clinically important message that is highlighted through images that clearly present the endoscopic features and histopathological findings, which constitutes an important learning tool. We think that these visual examples can be of great importance to remind physicians of this potential adverse event that can be easily forgotten or even a potential equivocal finding if careful analysis of the patient’s history is not performed.

 

References

1 Vente MA, Wondergem M, van der Tweel I, van den Bosch MA, Zonnenberg BA, Lam MG, et al. Yttrium-90 microsphere radioembolization for the treatment of liver malignancies: a structured meta-analysis. Eur Radiol. 2009 Apr;19(4):951–9.

2 Ogawa F, Mino-Kenudson M, Shimizu M, Ligato S, Lauwers GY. Gastroduodenitis associated with yttrium 90-microsphere selective internal radiation: an iatrogenic complication in need of recognition. Arch Pathol Lab Med. 2008 Nov;132(11):1734–8.

3 Kothari S, Li Y, Berkelhammer C, Almouradi T. Radiation gastritis after Yttrium-90 radioembolization. Gastrointest Endosc. 2018 Dec;88(6):965–6.

 

Statement of Ethics

This work is not a human trial. Data provided in this case report do not identify the patient.

Disclosure Statement

The authors have no potential conflicts of interest.

Funding Sources

The authors did not receive financial support for this study.

 

^* Corresponding author.

Rui Castro

Department of Gastroenterology, Portuguese Oncology Institute of Porto

Rua Dr. António Bernardino de Almeida

PT–4450-590 Porto (Portugal)

rui.arrais.castro@gmail.com

 

Received: October 7, 2019; Accepted: December 30, 2019

 

Author Contributions

All authors contributed equally to this paper with the conception and design of the study, literature review and analysis, drafting, critical revision and editing, and final approval of the final version.